These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 11986214)

  • 1. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
    Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
    Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis.
    Francischetti IM; Mather TN; Ribeiro JM
    Thromb Haemost; 2004 May; 91(5):886-98. PubMed ID: 15116248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant expression of Ixolaris, a Kunitz-type inhibitor from the tick salivary gland, for NMR studies.
    De Paula VS; Silva FHS; Francischetti IMB; Monteiro RQ; Valente AP
    Protein Expr Purif; 2017 Nov; 139():49-56. PubMed ID: 28734839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.
    Monteiro RQ; Rezaie AR; Bae JS; Calvo E; Andersen JF; Francischetti IM
    Protein Sci; 2008 Jan; 17(1):146-53. PubMed ID: 18042685
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    De Paula VS; Silva FHS; Francischetti IMB; Monteiro RQ; Valente AP
    Biomol NMR Assign; 2017 Oct; 11(2):293-296. PubMed ID: 28856584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
    Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
    J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
    Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
    J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade.
    Nazareth RA; Tomaz LS; Ortiz-Costa S; Atella GC; Ribeiro JM; Francischetti IM; Monteiro RQ
    Thromb Haemost; 2006 Jul; 96(1):7-13. PubMed ID: 16807644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
    Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition.
    De Paula VS; Sgourakis NG; Francischetti IMB; Almeida FCL; Monteiro RQ; Valente AP
    Blood; 2019 Aug; 134(8):699-708. PubMed ID: 31133602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
    Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
    Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).
    Dockal M; Hartmann R; Fries M; Thomassen MC; Heinzmann A; Ehrlich H; Rosing J; Osterkamp F; Polakowski T; Reineke U; Griessner A; Brandstetter H; Scheiflinger F
    J Biol Chem; 2014 Jan; 289(3):1732-41. PubMed ID: 24275667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
    Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
    Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
    J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Camerer E; Huang W; Coughlin SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.
    Huang Q; Neuenschwander PF; Rezaie AR; Morrissey JH
    J Biol Chem; 1996 Sep; 271(36):21752-7. PubMed ID: 8702971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterisation of vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi.
    Oliveira DG; Alvarez-Flores MP; Lopes AR; Chudzinski-Tavassi AM
    Thromb Haemost; 2012 Sep; 108(3):570-8. PubMed ID: 22782262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.